Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 335

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 335
---
, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state’s registration or qualification requirement is available and complied with.

The Selling Shareholder is
an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

The Selling Shareholder has
informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our Depositary Shares that
it has acquired and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms
then prevailing or at prices related to the then current market price. Each such registered broker-dealer will be an underwriter within
the meaning of Section 2(a)(11) of the Securities Act. The Selling Shareholder has informed us that each such broker-dealer will receive
commissions from the Selling Shareholder that will not exceed customary brokerage commissions.

Brokers, dealers, underwriters
or agents participating in the distribution of our Depositary Shares offered by this prospectus may receive compensation in the form of
commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the Selling
Shareholder through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of our Depositary
Shares sold by the Selling Shareholder may be less than or in excess of customary commissions. Neither we nor the Selling Shareholder
can presently estimate the amount of compensation that any agent will receive from any purchasers of our common stock sold by the Selling
Shareholder.

We know of no existing arrangements
between the Selling Shareholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of
our Depositary Shares offered by this prospectus.

We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the Selling Shareholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the